Bilaketaren emaitzak - Elizabeth Berry‐Kravis

Findu emaitzak
  1. 1
    Epilepsy in fragile X syndrome

    Epilepsy in fragile X syndrome nork Elizabeth Berry‐Kravis

    Argitaratua 2002
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Targeted treatments for fragile X syndrome

    Targeted treatments for fragile X syndrome nork Elizabeth Berry‐Kravis, Andrew Knox, Crystal Hervey

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond

    Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond nork Christina Groß, Elizabeth Berry‐Kravis, Gary J. Bassell

    Argitaratua 2011
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Fragile X: Leading the Way for Targeted Treatments in Autism

    Fragile X: Leading the Way for Targeted Treatments in Autism nork Lulu W. Wang, Elizabeth Berry‐Kravis, Randi J. Hagerman

    Argitaratua 2010
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

    Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome nork Elizabeth Berry‐Kravis, Allison Sumis, Crystal Hervey, Shaguna Mathur

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back

    Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back nork Christina Groß, Anne Hoffmann, Gary J. Bassell, Elizabeth Berry‐Kravis

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome

    A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome nork Michelle Lee, Gary E. Martin, Elizabeth Berry‐Kravis, Molly Losh

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Fragile X Syndrome and Targeted Treatment Trials

    Fragile X Syndrome and Targeted Treatment Trials nork Randi J. Hagerman, Julie C. Lauterborn, Jacky Au, Elizabeth Berry‐Kravis

    Argitaratua 2011
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Early‐phase ERK activation as a biomarker for metabolic status in fragile X syndrome

    Early‐phase ERK activation as a biomarker for metabolic status in fragile X syndrome nork Ning Weng, Ivan Jeanne Weiler, Allison Sumis, Elizabeth Berry‐Kravis, William T. Greenough

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome

    Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome nork Faraz Farzin, Felicia Scaggs Huang, Crystal Hervey, Elizabeth Berry‐Kravis, David Hessl

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature

    Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature nork Alexander Kolevzon, Elsa Delaby, Elizabeth Berry‐Kravis, Joseph D. Buxbaum, Catalina Betancur

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Cholesterol levels in Fragile X syndrome

    Cholesterol levels in Fragile X syndrome nork Elizabeth Berry‐Kravis, Rebecca Levin, Haroon Shah, Shaguna Mathur, Jennifer C. Darnell, Bichun Ouyang

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Improving IQ measurement in intellectual disabilities using true deviation from population norms

    Improving IQ measurement in intellectual disabilities using true deviation from population norms nork Stephanie M. Sansone, Andrea Schneider, Erika Bickel, Elizabeth Berry‐Kravis, Christina R. Prescott, David Hessl

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)

    Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS) nork Andrew Knox, Andrea Schneider, Floridette Abucayan, Crystal Hervey, Christina Tran, David Hessl, Elizabeth Berry‐Kravis

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Outcome Measures for Clinical Trials in Fragile X Syndrome

    Outcome Measures for Clinical Trials in Fragile X Syndrome nork Elizabeth Berry‐Kravis, David Hessl, Leonard Abbeduto, Allan L. Reiss, Andrea Beckel‐Mitchener, Tiina K. Urv

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities

    Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities nork Jayne Dixon Weber, Elizabeth G. Smith, Elizabeth Berry‐Kravis, Diego Cadavid, David Hessl, Craig A. Erickson

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Development of an Expressive Language Sampling Procedure in Fragile X Syndrome

    Development of an Expressive Language Sampling Procedure in Fragile X Syndrome nork Elizabeth Berry‐Kravis, Emily R. Doll, Audra Sterling, Sara T. Kover, Susen M. Schroeder, Shaguna Mathur, Leonard Abbeduto

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    White matter disease and cognitive impairment in <i>FMR1</i> premutation carriers

    White matter disease and cognitive impairment in <i>FMR1</i> premutation carriers nork Christopher M. Filley, Mark S. Brown, Karen Onderko, Megan Ray, Rachael E. Bennett, Elizabeth Berry‐Kravis, Jim Grigsby

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    The Apolipoprotein E ε4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons

    The Apolipoprotein E ε4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons nork Julie A. Schneider, Julia L. Bienias, R. J. Wilson, Elizabeth Berry‐Kravis, Denis A. Evans, David A. Bennett

    Argitaratua 2005
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Activation of Peroxisome Proliferator-activated Receptor α Induces Lysosomal Biogenesis in Brain Cells

    Activation of Peroxisome Proliferator-activated Receptor α Induces Lysosomal Biogenesis in Brain Cells nork Arunava Ghosh, Malabendu Jana, Khushbu K. Modi, Frank J. Gonzalez, Katherine B. Sims, Elizabeth Berry‐Kravis, Kalipada Pahan

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: